DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES

Size: px
Start display at page:

Download "DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES"

Transcription

1 DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES Extracts from a review article by KN North and KJ Jones: Recent advances in diagnosis of the childhood muscular dystrophies Journal of Paediatrics and Child Health (1997) 33, Recent advances in molecular genetics research have revolutionised our understanding of the childhood muscular dystrophies. The first breakthrough came in 1987, with the identification of the gene for dystrophin, the protein that is abnormal in X-linked Duchenne muscular dystrophy. Dystrophin is bound to a complex of proteins in the muscle membrane, and primary abnormalities of these proteins have now been identified as the cause of some autosomally inherited forms of muscular dystrophy. A group of transmembrane proteins known as α- (adhalin), β-, γ- and δ-sarcoglycan are deficient in autosomal recessive limbgirdle muscular dystrophy, and the extracellular matrix protein merosin (α2-laminin), is deficient in a subset of patients with congenital muscular dystrophy. Identification of primary deficiencies in these dystrophin associated proteins will result in improved diagnostic accuracy, more accurate genetic counselling and, in some cases, the availability of prenatal diagnosis. Definition and Classification The myopathies are primary disorders of muscle, characterised by lower motor neurone weakness, and subdivided on the basis of the presence or absence of specific ultrastructural changes on muscle biopsy. Muscular dystrophies are genetically determined myopathies, not associated with specific ultrastructural abnormalities, but with dystrophic changes on muscle biopsy, that is an increase in connective tissue, degenerating and regenerating fibres and marked variation in fibre size. Classification of the muscular dystrophies has been based historically on a combination of clinical features including age of onset, clinical severity and rate of progression, distribution of muscle weakness and pattern of inheritance. In 1868, Duchenne described the rapidly progressive, pseudohypertrophic type of muscular dystrophy in boys that now bears his name. Weakness predominantly affects the limb girdle muscles. Becker muscular dystrophy is a related disorder (see below), with milder and more heterogeneous clinical manifestations. Other disorders distinguished by their characteristic pattern of weakness include facioscapulohumeral dystrophy, an autosomal dominant disorder affecting predominantly the facial and shoulder girdle muscles; and Emery-Dreifuss muscular dystrophy, an X-linked disorder with slowly progressive humero-peroneal muscle weakness and cardiomyopathy. Batten, in 1903, was the first to describe a muscular dystrophy presenting at birth, which was later called dystrophica muscularis congenita. Congenital muscular dystrophy is the term now used to describe a group of disorders presenting at birth or within the first few months of life, with static or slowly progressive muscle weakness, often associated with hypotonia, and variable involvement of the respiratory and bulbar muscles. The congenital muscular dystrophies are subclassified on the basis of the presence or absence of structural involvement of the central nervous system. Fukuyama congenital muscular dystrophy, Walker-Warburg syndrome and Muscle-eye-brain disease are associated with structural abnormalities of the brain, severe mental retardation and seizures; the latter two disorders with ocular malformations. Pure or classical congenital muscular dystrophy has

2 traditionally been defined as having no clinical involvement of the central nervous system and normal intellect. Although the brain is structurally normal, a subset of patients has been identified with white matter changes on CT or MRI. Muscular dystrophies that do not fall into these clinically defined groups have been classified historically as the limb-girdle muscular dystrophies, a heterogeneous group of disorders with marked clinical variability. The existence of limb-girdle muscular dystrophy as a separate entity has been challenged, and several disorders previously included in this group, such as Becker muscular dystrophy, are now distinguishable on a genetic basis. 1 In this article we will summarise recent advances in the understanding of the molecular pathogenesis of the muscular dystrophies, which have further clarified the classification of the limb-girdle muscular dystrophies and confirmed their existence as a separate entity. These advances will result in improved diagnostic accuracy, more accurate genetic counselling, and in some cases the availability of prenatal diagnosis.

3 Approach to the Diagnosis of the Childhood Muscular Dystrophies From p.197 Recent Advances in Diagnosis of the Childhood Muscular Dystrophies Muscle Weakness CK NORMAL ELEVATED Muscular dystrophy unlikely: consider other diagnoses MALE FEMALE DNA Analysis for dystrophin gene abnormalities Deletion detected No deletion detected Deletion not informative for severity Muscle Biopsy Routine histopathology dystrophin analysis (immunocytochemistry and Western Blot) Deletion informative for severity Positive family history ABNORMAL DYSTROPHIN NORMAL DYSTROPHIN DIAGNOSIS OF DYSTROPHINOPATHY (DMD or BMD) Merosin and adhalin analysis ie. Duchenne muscular dystrophy or Becker muscular dystrophy

4 As described above, the cloning of the dystrophin gene in 1987 led to a sequence of advances that have revolutionised the classification and diagnosis of the muscular dystrophies. Current classification of the limb-girdle muscular dystrophies (in terms of the mode of inheritance and gene localisation) is outlined in Table 1. When a patient presents with weakness in a pattern suggestive of a primary muscle disorder, ie predominantly proximal muscle involvement with wasting and diminished power, hypotonia, hyporeflexia +/- calf hypertrophy or contractures, we would suggest an approach to diagnostic testing as outlined in Figure 3. Serum creatine kinase (CK) is a useful screening test, as elevation above 1000 U/L is suggestive of a muscular dystrophy. Note that CK can be normal in some patients with a dystrophic biopsy. CK is also elevated in two thirds of female carriers of a dystrophin gene abnormality. 1 EMG is not useful in the differentiation of the muscular dystrophies as the findings are non specific, showing a myopathic pattern of low amplitude, polyphasic potentials of short duration. Muscle ultrasound and muscle MRI may be helpful in differentiating between a myopathy and a neuropathy, and in determining the extent of muscle involvement. If there is a high index of suspicion and the CK is elevated, EMG and imaging studies may be bypassed to proceed directly to muscle biopsy or DNA testing (see below). A dystrophic picture on muscle biopsy is characterised by marked variation in fibre size, increased connective tissue and the presence of degenerating and regenerating fibres (Figure 4). Biopsy is useful to exclude congenital myopathies with specific ultrastructural changes, such as nemaline rods or central cores, or a primary neuropathic disorder. Immunocytochemical studies may be performed on frozen sections from muscle biopsy using antibodies that react specifically with individual muscle proteins. Using antibodies to dystrophin, the protein may be shown to be completely deficient (Duchenne muscular dystrophy), or decreased in quantity (Becker muscular dystrophy) (Figure 5). Further quantitation of specific proteins and identification of proteins with abnormal molecular weight may be performed using Western blotting techniques. A similar process can be performed for the dystrophin associated proteins, and in addition to dystrophin, there are currently commercially available antibodies to adhalin (α-sarcoglycan) and merosin (α2 laminin) (Figure 6). If adhalin is abnormal on immunocytochemistry this may be due to a primary deficiency of adhalin or it may be the result of an abnormality of one of the other sarcoglycans. Primary and secondary sarcoglycan abnormalities can only be distinguished by the identification of a gene mutation. DNA diagnosis is now widely available for the X-linked dystrophinopathies and analysis of DNA from peripheral blood by PCR (polymerase chain reaction) results in detection of a dystrophin gene mutation in approximately 60% of patients with Duchenne or Becker muscular dystrophy. In some cases it is possible to predict clinical severity based on the nature of the mutation. This may obviate the need for muscle biopsy, however quantification of dystrophin by immunocytochemistry and Western blotting is more reliable in terms of predicting prognosis. DNA testing may ultimately replace muscle biopsy in the diagnosis of the muscular dystrophies, however, at present, mutation analysis for proteins other than dystrophin is available only on a research basis. Other investigations may be useful in determining the complete clinical phenotype associated with a particular muscular dystrophy. Cranial MRI may show leukodystrophic changes in merosin negative congenital muscular dystrophy and structural brain abnormalities in the non-classical congenital muscular dystrophies (eg. Fukuyama). ECG

5 and echocardiogram may show evidence of cardiac involvement in the dystrophinopathies, sarcoglycanopathies and Emery-Dreifuss muscular dystrophy. Improved diagnostic accuracy has resulted in more accurate genetic counselling, and in some cases prenatal diagnosis. Prenatal diagnosis is available for the dystrophinopathies (on chorionic villous biopsy or amniocentesis) by direct genetic testing for dystrophin gene abnormalities or by linkage studies in cases where the gene mutation is not known. Immunocytochemical analysis can be performed on chorionic villous biopsy for merosin abnormalities, as this protein is expressed in placental tissue. The technique of fetal muscle biopsy is currently being developed, and may enable direct study of protein expression in the fetal muscle while in utero. In addition, mutational analysis for the other protein abnormalities currently only in performed in research laboratories, will become more widely available, offering further prenatal testing options.

Neuromuscular diseases

Neuromuscular diseases Neuromuscular diseases Spinal muscular atrophy - SMA characterized by degeneration of the anterior horn cells in the spinal cord and motor nuclei in the lower brainstem. SMA type 1, is also known as Werdnig-

More information

Limb girdle muscular dystrophies (LGMDs)

Limb girdle muscular dystrophies (LGMDs) Limb girdle muscular dystrophies (LGMDs) This factsheet is for all people for whom a diagnosis of limb girdle muscular dystrophy (LGMD) has been suggested. This is a complicated subject since there are

More information

Muscular Dystrophy. By. Tina Strauss

Muscular Dystrophy. By. Tina Strauss Muscular Dystrophy By. Tina Strauss Story Outline for Presentation on Muscular Dystrophy What is Muscular Dystrophy? Signs & Symptoms Types When to seek medical attention? Screening and Diagnosis Treatment

More information

Central core disease

Central core disease Central core disease Central core disease falls under the umbrella of congenital myopathies which are characterised by muscle weakness and wasting. It is a rare condition, and symptoms are usually present

More information

Genetic Testing for Duchenne and Becker Muscular Dystrophy

Genetic Testing for Duchenne and Becker Muscular Dystrophy Corporate Medical Policy Genetic Testing for Duchenne and Becker Muscular Dystrophy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_duchenne_and_becker_muscular_dystrophy

More information

Rigid spine syndrome (RSS) (Congenital muscular dystrophy with rigidity of the spine, including RSMD1)

Rigid spine syndrome (RSS) (Congenital muscular dystrophy with rigidity of the spine, including RSMD1) Rigid spine syndrome (RSS) (Congenital muscular dystrophy with rigidity of the spine, including RSMD1) What is RSMD1? The congenital muscular dystrophies are a group of conditions which share early presentation

More information

Carrier detection tests and prenatal diagnosis

Carrier detection tests and prenatal diagnosis Carrier detection tests and prenatal diagnosis There are several types of muscular dystrophy and about 50 neuromuscular conditions, all of which fall under the umbrella of the Muscular Dystrophy Campaign.

More information

Pediatric Neuromuscular Disorders: Transitions to Adult Providers

Pediatric Neuromuscular Disorders: Transitions to Adult Providers Pediatric Neuromuscular Disorders: Transitions to Adult Providers 29 th Annual Update in Physical Medicine and Rehabilitation January 29, 2015 Russell Butterfield MD, PhD Assistant Professor, Departments

More information

SKELETAL MUSCLE PATHOLOGY. Pathophysiological changes of muscles Atrophy and hypertrophy of muscles

SKELETAL MUSCLE PATHOLOGY. Pathophysiological changes of muscles Atrophy and hypertrophy of muscles SKELETAL MUSCLE PATHOLOGY Pathophysiological changes of muscles Atrophy and hypertrophy of muscles Muscle atrophies Muscle atrophy is defined as a decrease in the mass of the muscle Physiologically: Muscle

More information

Facts About Rare Muscular Dystrophies

Facts About Rare Muscular Dystrophies The fact sheets have been adapted from material originally prepared by MDA USA with their kind permission. We are grateful for providing this valuable and informative material Facts About Rare Muscular

More information

Becker Muscular Dystrophy

Becker Muscular Dystrophy Muscular Dystrophy A Case Study of Positional Cloning Described by Benjamin Duchenne (1868) X-linked recessive disease causing severe muscular degeneration. 100 % penetrance X d Y affected male Frequency

More information

Duchenne muscular dystrophy

Duchenne muscular dystrophy Duchenne muscular dystrophy Penny Southall, mum of Dan Hanson: My son, Dan, was diagnosed with Duchenne muscular dystrophy when he was three years old. I know the diagnosis can be devastating. Like we

More information

MUSCULAR DYSTROPHY GENETICS AND TESTING

MUSCULAR DYSTROPHY GENETICS AND TESTING MUSCULAR DYSTROPHY GENETICS AND TESTING Information to help you make an informed choice about testing. MUSCULAR DYSTROPHY 111 BOUNDARY ROAD NORTH MELBOURNE 3051 AUSTRALIA +61 3 9320 9555 MDA.ORG.AU Genetic

More information

Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy

Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy Muscular dystrophy pathology: muscle fiber degeneration and regeneration Muscular

More information

Muscular dystrophy: basic facts

Muscular dystrophy: basic facts Muscular dystrophy: basic facts - heterogenous group of inherited disorders characterized by progressive muscle weakness and wasting (regeneration of muscle tissue fails) - most apparent or symptomatic

More information

Duchenne muscular dystrophy (DMD)

Duchenne muscular dystrophy (DMD) Duchenne muscular dystrophy (DMD) What is Duchenne muscular dystrophy or DMD? Muscular Dystrophy is a group of inherited muscle disorders, in which muscles weaken over time. Duchenne muscular dystrophy

More information

Neonatal Hypotonia. Clinical Approach to Floppy Baby

Neonatal Hypotonia. Clinical Approach to Floppy Baby Neonatal Hypotonia Clinical Approach to Floppy Baby Hypotonia in the newborn is a common presenting feature of systemic illness or neurologic dysfunction at any level of the central or peripheral nervous

More information

an evaluation of histopathology and clinical value during a 5-year period

an evaluation of histopathology and clinical value during a 5-year period Upsala Journal of Medical Sciences. 2009; 114: 4145 ORIGINAL ARTICLE Muscle biopsies in children* an evaluation of histopathology and clinical value during a 5-year period MARIUS KURÅS SKRAM 1, SASHA GULATI

More information

How to manage a family with two cases of Dilated Cardiomyopathy. Dr Edward Blair Oxford

How to manage a family with two cases of Dilated Cardiomyopathy. Dr Edward Blair Oxford How to manage a family with two cases of Dilated Cardiomyopathy OR Dr Edward Blair Oxford Lets give the geneticist the. Idiopathic Dilated Cardiomyopathy Unexplained (DCM) LV dilatation & depressed contractility

More information

FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies

FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies Raymond A. Huml, MS, DVM, RAC Executive Director, Head, Global Biosimilars Business Development and Strategic Planning, Quintiles

More information

Minicore (multicore) myopathy

Minicore (multicore) myopathy Minicore (multicore) myopathy Minicore myopathy, also called, multicore myopathy and multiminicore myopathy, falls under the umbrella of congenital myopathies. These are a group of conditions characterised

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA

CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA Cytogenetics is the study of chromosomes and their structure, inheritance, and abnormalities. Chromosome abnormalities occur in approximately:

More information

UNIT 13 (OPTION) Genetic Abnormalities

UNIT 13 (OPTION) Genetic Abnormalities Unit 13 Genetic Abnormailities 1 UNIT 13 (OPTION) Genetic Abnormalities Originally developed by: Hildur Helgedottir RN, MN Revised (2000) by: Marlene Reimer RN, PhD, CCN (C) Associate Professor Faculty

More information

What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives

What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives What does the career involve? Explore family histories to identify risks Reducing risks

More information

Facioscapulohumeral Muscular Dystrophy

Facioscapulohumeral Muscular Dystrophy Facioscapulohumeral Muscular Dystrophy What is Facioscapulohumeral Muscular Dystrophy? Facioscapulohumeral (FSH) Muscular Dystrophy is the medical term for a disorder of the muscles. FSH most often affects

More information

Muscle Physiology and the. Pathology of Muscular Dystrophy

Muscle Physiology and the. Pathology of Muscular Dystrophy Muscle Physiology and the Pathology of Muscular Dystrophy Angela Tompkins February 23, 2010 Everglades University Biology 1 Muscle Physiology and the Pathology of Muscular Dystrophy Humans are able to

More information

Joan Anusas Cardiomyopathy Nurse Specialist Inherited Cardiac Conditions Clinic

Joan Anusas Cardiomyopathy Nurse Specialist Inherited Cardiac Conditions Clinic Joan Anusas Cardiomyopathy Nurse Specialist Inherited Cardiac Conditions Clinic Background to clinic Cardiomyopathy Nurse Specialist post created in March 2005. Post funded by Cardiomyopathy Association

More information

Oculopharyngeal muscular dystrophy (OPMD)

Oculopharyngeal muscular dystrophy (OPMD) Oculopharyngeal muscular dystrophy (OPMD) The term muscular dystrophy is used to cover a wide range of conditions which have in common progressive muscle weakness due to an inherited genetic defect (mutation).

More information

genetic carrier screening for spinal muscular atrophy results You Can trust

genetic carrier screening for spinal muscular atrophy results You Can trust genetic carrier screening for spinal muscular atrophy results You Can trust Spinal Muscular Atrophy (SMA) Carrier screening What Is SMA Carrier screening? Carrier screening tests help identify individuals

More information

Muscle weakness and atrophy Muscle weakness is the main cause of disability in myotonic dystrophy. The problem tends to affect some

Muscle weakness and atrophy Muscle weakness is the main cause of disability in myotonic dystrophy. The problem tends to affect some Skeletal muscles Symptoms Myotonia Sustained muscle contraction (myotonia) is a distinctive aspect of myotonic dystrophy. The presence of myotonia is not the most disabling aspect of DM, but it is the

More information

LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD

LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD 2 Outline Genetics 101: Basic Concepts and Myth Busting Inheritance Patterns

More information

The NeurOmics team at a recent project meeting

The NeurOmics team at a recent project meeting Introduction Welcome to the NeurOmics project newsletter. This is the second edition and comes after the project has been underway for just over a year. This means that whilst we still have lots of work

More information

2013/14 NHS STANDARD CONTRACT FOR DIAGNOSTIC SERVICE FOR RARE NEUROMUSCULAR DISORDERS (ALL AGES)

2013/14 NHS STANDARD CONTRACT FOR DIAGNOSTIC SERVICE FOR RARE NEUROMUSCULAR DISORDERS (ALL AGES) D04/S(HSS)/a 2013/14 NHS STANDARD CONTRACT FOR DIAGNOSTIC SERVICE FOR RARE NEUROMUSCULAR DISORDERS (ALL AGES) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATIONS Service Specification No.

More information

Neuromuscular disorders Development of consensus for diagnosis and standards of care. Thomas Sejersen, Pediatric neurology

Neuromuscular disorders Development of consensus for diagnosis and standards of care. Thomas Sejersen, Pediatric neurology Neuromuscular disorders Development of consensus for diagnosis and standards of care Thomas Sejersen, Pediatric neurology What are neuromuscular disorders? How does the field of neuromuscular disorders

More information

Preimplantation Genetic Diagnosis. Evaluation for single gene disorders

Preimplantation Genetic Diagnosis. Evaluation for single gene disorders Preimplantation Genetic Diagnosis Evaluation for single gene disorders What is Preimplantation Genetic Diagnosis? Preimplantation genetic diagnosis or PGD is a technology that allows genetic testing of

More information

Obstetrical Ultrasound and Prenatal Diagnostic Center

Obstetrical Ultrasound and Prenatal Diagnostic Center Obstetrical Ultrasound and Prenatal Diagnostic Center Prenatal Diagnosis: Options and Opportunities Learn about various screening options including Early Risk Assessment (ERA), now available to women of

More information

Myotonic Dystrophy: Making an Informed Choice About Genetic Testing

Myotonic Dystrophy: Making an Informed Choice About Genetic Testing Myotonic Dystrophy: Making an Informed Choice About Genetic Testing Written by: Corrine O Sullivan Smith, MS, CGC Robin L. Bennett, MS, CGC Thomas D. Bird, MD Medical Genetics and Neurology University

More information

Neuromuscular disorders in children

Neuromuscular disorders in children Programma Spierziekten bij Kinderen Nieuwe inzichten Algemene inleiding- Klinische symptomen Respiratoire aspecten Orthopedische aspecten- beleid Cardiale aspecten Nieuwe therapeutische strategieën N.Goemans

More information

News. Report from Cypress: The Discovery of Protomyonecrosis

News. Report from Cypress: The Discovery of Protomyonecrosis Report from Cypress: The Discovery of Protomyonecrosis Introduction The central nervous system is made up of the brain and the spinal cord and together form a kind of perceptual computer that keeps us

More information

Human Mendelian Disorders. Genetic Technology. What is Genetics? Genes are DNA 9/3/2008. Multifactorial Disorders

Human Mendelian Disorders. Genetic Technology. What is Genetics? Genes are DNA 9/3/2008. Multifactorial Disorders Human genetics: Why? Human Genetics Introduction Determine genotypic basis of variant phenotypes to facilitate: Understanding biological basis of human genetic diversity Prenatal diagnosis Predictive testing

More information

SPINAL MUSCULAR ATROPHY

SPINAL MUSCULAR ATROPHY SPINAL MUSCULAR ATROPHY Last updated April 2010 What is Spinal Muscular Atrophy? Spinal Muscular Atrophy (SMA) is a genetic, motor neuron disorder. Lower motor neurons are nerve cells in the spinal cord

More information

Facts About. Rare Muscular Dystrophies (Congenital, Distal, Emery-Dreifuss and Oculopharyngeal)

Facts About. Rare Muscular Dystrophies (Congenital, Distal, Emery-Dreifuss and Oculopharyngeal) Facts About Rare Muscular Dystrophies (Congenital, Distal, Emery-Dreifuss and Oculopharyngeal) Updated December 2009 Mike Neufeldt Dear Friends: When I was about a year old, my parents noticed something

More information

Muscular Dystrophy: Stem Cell Therapy

Muscular Dystrophy: Stem Cell Therapy by Caitlin Pederson Abstract: Genetic disorders affect many people, and muscular dystrophy is a disorder that can greatly decrease the quality of life. Finding treatment to stop or prevent the loss of

More information

INTRODUCTION TO THE UK CURRICULUM IN CLINICAL GENETICS

INTRODUCTION TO THE UK CURRICULUM IN CLINICAL GENETICS INTRODUCTION TO THE UK CURRICULUM IN CLINICAL GENETICS Clinical Geneticists work in multidisciplinary regional genetic centres in the UK, in close collaboration with laboratory scientists, clinical co-workers

More information

Preimplantation Genetic Diagnosis (PGD) in Western Australia

Preimplantation Genetic Diagnosis (PGD) in Western Australia Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome

More information

About The Causes of Hearing Loss

About The Causes of Hearing Loss About 1 in 500 infants is born with or develops hearing loss during early childhood. Hearing loss has many causes: some are genetic (that is, caused by a baby s genes) or non-genetic (such as certain infections

More information

Central Nervous System

Central Nervous System Central Nervous System Symptoms Cognitive impairment Intellectual disability is expected in individuals with clinically evident myotonic dystrophy at birth. In less severe forms of the disease, cognitive

More information

Comprehensive List of Neuromuscular Disorders Covered by Muscular Dystrophy Canada

Comprehensive List of Neuromuscular Disorders Covered by Muscular Dystrophy Canada Comprehensive List of Neuromuscular Disorders Covered by Muscular Dystrophy Canada Neuromuscular disorders is a general term that refers to diseases that affect any part of the nerve and muscle. These

More information

1: Motor neurone disease (MND)

1: Motor neurone disease (MND) 1: Motor neurone disease (MND) This section provides basic facts about motor neurone disease (MND) and its diagnosis. The following information is an extracted section from our full guide Living with motor

More information

Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy (SMA) Spinal Muscular Atrophy (SMA) What Is Spinal Muscular Atrophy? QuickFACTS: What: Spinal Muscular Atrophy Who: Anyone When: At any age Where: Motor nerve cells Why: Various genetic causes Muscular Dystrophy

More information

Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006

Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006 Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics January 2006 1. BACKGROUND ICSI has been shown to be effective for male factor infertility and it also

More information

Usher Syndrome Genetics

Usher Syndrome Genetics Usher Syndrome Genetics October 2012 Page 1 of 20 Introduction Usher syndrome is a genetic or inherited condition that affects hearing, vision and balance The sight loss is caused by an eye condition known

More information

Genetic Basis of Cardiomyopathy

Genetic Basis of Cardiomyopathy Genetic Basis of Cardiomyopathy A GUIDE FOR PATIENTS AND FAMILIES LABORATORY FOR MOLECULAR MEDICINE This booklet has been prepared for patients, families and healthcare professionals who are interested

More information

BCS1L COQ2 POLG. Genetic Testing for Mitochondrial Disorders: A Guide for Patients

BCS1L COQ2 POLG. Genetic Testing for Mitochondrial Disorders: A Guide for Patients Mito COX10 BCS1L COQ2 POLG Genetic Testing for Mitochondrial Disorders: A Guide for Patients KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS Mitochondrial Disorders What are mitochondria?

More information

Disease Modifying Therapy for DMD: Utrophin Modulation Programme

Disease Modifying Therapy for DMD: Utrophin Modulation Programme Disease Modifying Therapy for DMD: Utrophin Modulation Programme PPMD Connect, June 2014 Legal Disclaimer FORWARD-LOOKING STATEMENTS This Document contains forward-looking statements. These statements

More information

National Centre for Medical Genetics Dublin, Ireland Division of Molecular Genetics. External Service Description Familial Breast/Ovarian Cancer

National Centre for Medical Genetics Dublin, Ireland Division of Molecular Genetics. External Service Description Familial Breast/Ovarian Cancer External Service Description Familial Breast/Ovarian Cancer 1 Background Pathogenic mutations in the tumour suppressor breast cancer genes BRCA1* and BRCA2** account for approximately 3-5% of all female

More information

Genetics of Turner syndrome. Rosemarie Kelly Principal genetic Counsellor National Centre for Medical Genetics

Genetics of Turner syndrome. Rosemarie Kelly Principal genetic Counsellor National Centre for Medical Genetics Genetics of Turner syndrome Rosemarie Kelly Principal genetic Counsellor National Centre for Medical Genetics National Centre for Medical Genetics Clinical Genetics Cytogenetics Molecular Genetics www.genetics.ie

More information

Genetic Mutations Cause Many Birth Defects:

Genetic Mutations Cause Many Birth Defects: Genetic Mutations Cause Many Birth Defects: What We Learned from the FORGE Canada Project Jan M. Friedman, MD, PhD University it of British Columbia Vancouver, Canada I have no conflicts of interest related

More information

Executive summary. Current prenatal screening

Executive summary. Current prenatal screening Executive summary Health Council of the Netherlands. NIPT: dynamics and ethics of prenatal screening. The Hague: Health Council of the Netherlands, 2013; publication no. 2013/34. In recent years, new tests

More information

Optional Tests Offered Before and During Pregnancy

Optional Tests Offered Before and During Pregnancy Plano Women s Healthcare Optional Tests Offered Before and During Pregnancy Alpha-Fetoprotein Test (AFP) and Quad Screen These are screening tests that can assess your baby s risk of having such birth

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) (A)-Testing

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISEASE/CONDITION POPULATION TRIAD Submitting laboratory: Cambridge RGC Approved: September 2012

More information

Fatty Acid Oxidation Disorders Galactosemia Biotinidase Deficiency

Fatty Acid Oxidation Disorders Galactosemia Biotinidase Deficiency Fatty Acid Oxidation Disorders Galactosemia Biotinidase Deficiency Dr. Kathy Grange, MD Division of Genetics and Genomic Medicine Department of Pediatrics Washington University School of Medicine What

More information

Diagnostic Scoring System for LQTS

Diagnostic Scoring System for LQTS Medical Coverage Policy Genetic Testing: Congenital Long QT Syndrome Device/Equipment Drug Medical Surgery Test Other Effective Date: 2/15/2011 Policy Last Updated: 2/21/2012 Prospective review is recommended/required.

More information

SOTOS SYNDROME FAMILY INFORMATION LEAFLET

SOTOS SYNDROME FAMILY INFORMATION LEAFLET SOTOS SYNDROME FAMILY INFORMATION LEAFLET WHAT IS SOTOS SYNDROME? Sotos syndrome is a genetic condition characterised by four cardinal features (table 1):- 1. Increased height above that expected for the

More information

Juvenile Dermatomyositis Joseph Junewick, MD FACR

Juvenile Dermatomyositis Joseph Junewick, MD FACR Juvenile Dermatomyositis Joseph Junewick, MD FACR 10/11/2015 History Child with several month history of weakness, arthralgias and palpable abnormalities at the knee Diagnosis Juvenile Dermatomyositis

More information

The following chapter is called "Preimplantation Genetic Diagnosis (PGD)".

The following chapter is called Preimplantation Genetic Diagnosis (PGD). Slide 1 Welcome to chapter 9. The following chapter is called "Preimplantation Genetic Diagnosis (PGD)". The author is Dr. Maria Lalioti. Slide 2 The learning objectives of this chapter are: To learn the

More information

Genetic Disorders HST.023. Spring 2003

Genetic Disorders HST.023. Spring 2003 Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Genetic Disorders HST.023 Spring 2003 Genetic Disorders Cytogenetic Disorders Gross

More information

First Trimester Screening for Down Syndrome

First Trimester Screening for Down Syndrome First Trimester Screening for Down Syndrome What is first trimester risk assessment for Down syndrome? First trimester screening for Down syndrome, also known as nuchal translucency screening, is a test

More information

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1 NORD Guides for Physicians #1 The National Organization for Rare Disorders Physician s Guide to Tyrosinemia Type 1 The original version of this booklet was made possible by donations in honor of Danielle

More information

Corporate Medical Policy Genetic Testing for Fanconi Anemia

Corporate Medical Policy Genetic Testing for Fanconi Anemia Corporate Medical Policy Genetic Testing for Fanconi Anemia File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_fanconi_anemia 03/2015 3/2016 3/2017 3/2016 Description

More information

X Linked Inheritance

X Linked Inheritance X Linked Inheritance Information for Patients and Families 2 X linked Inheritance The following will give you information about what X linked inheritance means and how X linked conditions are inherited.

More information

REQUEST FOR IMAGe SYNDROME TESTING

REQUEST FOR IMAGe SYNDROME TESTING REQUEST FOR IMAGe SYNDROME TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION* FIRST NAME MI LAST

More information

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association 6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising

More information

Management in the pre-hospital setting

Management in the pre-hospital setting Management in the pre-hospital setting Inflammation of the joints Two main types: Osteoarthritis - cartilage loss from wear and tear Rheumatoid arthritis - autoimmune disorder Affects all age groups,

More information

SIXTY-THIRD WORLD HEALTH ASSEMBLY A63/10 Provisional agenda item April Birth defects. Report by the Secretariat

SIXTY-THIRD WORLD HEALTH ASSEMBLY A63/10 Provisional agenda item April Birth defects. Report by the Secretariat SIXTY-THIRD WORLD HEALTH ASSEMBLY A63/10 Provisional agenda item 11.7 1 April 2010 Birth defects Report by the Secretariat 1. The report aims to inform the discussion on birth defects, including definition,

More information

Mucolipidoses. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health

Mucolipidoses. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Mucolipidoses U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Mucolipidoses What are the mucolipidoses? The mucolipidoses (ML) are a group of inherited metabolic diseases that

More information

Mendelian inheritance and the

Mendelian inheritance and the Mendelian inheritance and the most common genetic diseases Cornelia Schubert, MD, University of Goettingen, Dept. Human Genetics EUPRIM-Net course Genetics, Immunology and Breeding Mangement German Primate

More information

This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive.

This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive. 11111 This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive. In summary Genes contain the instructions for

More information

ANATOMY & PHYSIOLOGY MODULE 2015/16

ANATOMY & PHYSIOLOGY MODULE 2015/16 ANATOMY & PHYSIOLOGY MODULE 2015/16 STUDENT INFORMATION MODULE CO-ORDINATOR: Email: edged@tcd.ie DEPARTMENT OF PHYSIOLOGY, BIOMEDICAL SCIENCES INSTITUTE, TRINITY COLLEGE, PEARSE STREET, DUBLIN 2. Module

More information

Information for Your Patients

Information for Your Patients Information for Your Patients What is first trimester risk assessment for Down syndrome? First trimester screening for Down syndrome, also known as nuchal translucency screening, is a test offered to women

More information

Facts About. Duchenne & Becker Muscular Dystrophies

Facts About. Duchenne & Becker Muscular Dystrophies Facts About Duchenne & Becker Muscular Dystrophies Updated December 2009 Michael Norton (foreground) with brother, John, and parents, Suzan and Terry. Dear Friends: When my husband, Terry, and I learned

More information

Patient Information. for Childhood

Patient Information. for Childhood Patient Information Genetic Testing for Childhood Hearing Loss Introduction This document describes the most common genetic cause of childhood hearing loss and explains the role of genetic testing. Childhood

More information

Developmental delay and Cerebral palsy. Present the differential diagnosis of developmental delay.

Developmental delay and Cerebral palsy. Present the differential diagnosis of developmental delay. Developmental delay and Cerebral palsy objectives 1. developmental delay Define developmental delay Etiologies of developmental delay Present the differential diagnosis of developmental delay. 2. cerebral

More information

EMG and the Electrodiagnostic Consultation for the Family Physician

EMG and the Electrodiagnostic Consultation for the Family Physician EMG and the Electrodiagnostic Consultation for the Family Physician Stephanie Kopey, D.O., P.T. 9/27/15 The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Marketing Committee

More information

Genetic Mutations. Indicator 4.8: Compare the consequences of mutations in body cells with those in gametes.

Genetic Mutations. Indicator 4.8: Compare the consequences of mutations in body cells with those in gametes. Genetic Mutations Indicator 4.8: Compare the consequences of mutations in body cells with those in gametes. Agenda Warm UP: What is a mutation? Body cell? Gamete? Notes on Mutations Karyotype Web Activity

More information

The Developing Person Through the Life Span 8e by Kathleen Stassen Berger

The Developing Person Through the Life Span 8e by Kathleen Stassen Berger The Developing Person Through the Life Span 8e by Kathleen Stassen Berger Chapter 3 Heredity and Environment PowerPoint Slides developed by Martin Wolfger and Michael James Ivy Tech Community College-Bloomington

More information

Electrodiagnostic Testing

Electrodiagnostic Testing Electrodiagnostic Testing Electromyogram and Nerve Conduction Study North American Spine Society Public Education Series What Is Electrodiagnostic Testing? The term electrodiagnostic testing covers a

More information

Cerebral palsy can be classified according to the type of abnormal muscle tone or movement, and the distribution of these motor impairments.

Cerebral palsy can be classified according to the type of abnormal muscle tone or movement, and the distribution of these motor impairments. The Face of Cerebral Palsy Segment I Discovering Patterns What is Cerebral Palsy? Cerebral palsy (CP) is an umbrella term for a group of non-progressive but often changing motor impairment syndromes, which

More information

Muscular Dystrophy and Multiple Sclerosis. ultimately lead to the crippling of the muscular system, there are many differences between these

Muscular Dystrophy and Multiple Sclerosis. ultimately lead to the crippling of the muscular system, there are many differences between these Battles 1 Becky Battles Instructor s Name English 1013 21 November 2006 Muscular Dystrophy and Multiple Sclerosis Although muscular dystrophy and multiple sclerosis are both progressive diseases that ultimately

More information

GENETIC TESTING AND MARFAN SYNDROME

GENETIC TESTING AND MARFAN SYNDROME GENETIC TESTING AND MARFAN SYNDROME Genetic testing for mutations in fibrillin-1 (FBN1) and other genes has become an important and reliable option to aid in the diagnosis of Marfan syndrome and related

More information

G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics

G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics One of every 500 newborns has bilateral permanent sensorineural hearing loss 40 db which makes it the most common

More information

Comprehensive Care for Duchenne Muscular Dystrophy

Comprehensive Care for Duchenne Muscular Dystrophy Comprehensive Care for Duchenne Muscular Dystrophy Brenda Wong, MD Cincinnati Children s Hospital Medical Center PPMD Annual Conference 2008 17 July 2008 Comprehensive Care for DMD Historical Perspective

More information

Objectives Role of Medical Genetics in Hearing Loss Evaluation. 5 y.o. boy with severe SNHL

Objectives Role of Medical Genetics in Hearing Loss Evaluation. 5 y.o. boy with severe SNHL Objectives Role of Medical Genetics in Hearing Loss Evaluation Millan Patel, MD UBC Dept. of Medical Genetics October 22, 2010 Case presentation to illustrate importance of defining syndromic hearing loss

More information

Prenatal screening and diagnostic tests

Prenatal screening and diagnostic tests Prenatal screening and diagnostic tests Contents Introduction 3 First trimester routine tests in the mother 3 Testing for health conditions in the baby 4 Why would you have a prenatal test? 6 What are

More information

CHROMOSOMES AND INHERITANCE

CHROMOSOMES AND INHERITANCE SECTION 12-1 REVIEW CHROMOSOMES AND INHERITANCE VOCABULARY REVIEW Distinguish between the terms in each of the following pairs of terms. 1. sex chromosome, autosome 2. germ-cell mutation, somatic-cell

More information

G-2d 2 Consent for Clinical DNA Sequencing Iowa Institute of Human Genetics

G-2d 2 Consent for Clinical DNA Sequencing Iowa Institute of Human Genetics G-2d 2 Consent for Clinical DNA Sequencing Iowa Institute of Human Genetics Contact: Richard JH Smith, MD; Colleen Campbell, PhD, MS, CGC DATE HOSP.# NAME BIRTH DATE This consent form describes the clinical

More information

BILE ACID SYNTHESIS AND METABOLISM DEFECTS

BILE ACID SYNTHESIS AND METABOLISM DEFECTS The Childhood Liver Disease Research Network strives to provide information and support to individuals and families affected by liver disease through its many research programs. BILE ACID SYNTHESIS AND

More information

Communicating with Families about Family History and Genetics

Communicating with Families about Family History and Genetics Communicating with Families about Family History and Genetics Abdallah F. Elias, M.D. Providence Genetics Clinic at Grant Creek & Florence Family Practice Department of Biomedical and Pharmaceutical Sciences

More information